Completed
Salmon in Pregnancy Study
NCT00801502
- Conditions
- Allergies, Asthma, Bronchial Diseases, +10 more
- Locations
-
- University of Southampton Southampton, United Kingdom
Clinical trial condition
Respiratory Hypersensitivity
Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.
4,455 public trials
324 recruiting studies
Respiratory Hypersensitivity trial results
NCT00410280
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of British Columbia Vancouver, British Columbia, Canada
- University of British Columbia Vancouver, British Columbia, Canada
- McMaster University Medical Hamilton, Ontario, Canada
- Hopital Laval Ste-Foy, Quebec, Canada
NCT02100267
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Showa University Clinical Research Center Setagaya-ku, Tokyo, Japan
NCT02108379
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Aarhus University, School of Public Health, Department of Environmental & Occupational Medicine Aarhus, Denmark
NCT01771120
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +11 more
- Locations
-
- Instituto CUF Porto Porto, Porto District, Portugal
NCT00217958
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT02273817
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified
NCT00590772
- Conditions
- Fatigue, Hypersensitivity, Hypersensitivity, Immediate, +14 more
- Locations
-
Not specified
NCT01277523
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.456.01004 Boehringer Ingelheim Investigational Site Stockton, California, United States
- 205.456.01008 Boehringer Ingelheim Investigational Site Normal, Illinois, United States
- 205.456.01003 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States
- 205.456.01007 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States
NCT01788813
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Kingston, Ontario, Canada